Skip to main content
FinSpry Logo
FinSpry
HAE logo
HAE
(NYSE)
Haemonetics Corporation
$108.80-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Haemonetics (HAE) Stock Price & Financial Analysis

Haemonetics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$107.00 - $109.57
52-Week High$92.25
52-Week Low$47.32
Open$109.24
Volume582.10K
Average Volume (3M)802.02K
Market Cap5.03B
Shares Outstanding46.22M
P/E Ratio (TTM)42.88
Forward P/E75.62
Price to Sales (P/S)3.13
Price to Book (P/B)5.24
EV/EBITDA18.38
Revenue (TTM)1.33B
Net Income (TTM)97.31M
Free Cash Flow (TTM)260.44M
EPS (TTM)$2.06
Profit Margin7.29%
Operating Margin18.15%
Return on Equity (ROE)12.22%
Debt to Equity1.54
50-Day MA$79.33
200-Day MA$69.68
52-Week Change67.98%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Haemonetics

What is the current stock price for HAE?

As of the latest trading session, HAE stock trades at $108.80. The 52-week range is $47.32–$92.25, with a day range of $107.00–$109.57.

What is the P/E ratio for HAE?

Haemonetics's trailing P/E ratio is 42.9, meaning investors pay $42.9 for every $1 of annual earnings. The forward P/E is 75.6, reflecting analyst expectations for future earnings. Haemonetics operates in the Healthcare sector.

Does HAE pay dividends?

Haemonetics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for HAE?

Based on 4 analysts, the consensus for HAE is Buy.

What is the market cap of HAE?

Haemonetics's market capitalization is $5.03B, classifying it as a mid-cap company. Haemonetics operates in the Healthcare sector within the Medical Devices industry.